Patents by Inventor Daniel J. Schneider
Daniel J. Schneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12079294Abstract: Methods and systems are provided for managing a GUI of a web browser. When a user interaction with a tab presentation control is detected, a horizontal tab strip having first navigation tab controls for a set of webpages is removed, and a vertical tab strip having second navigation tab controls for the same set of webpages is displayed in a vertical column in the browser. In response to detecting a user hover interaction with the vertical tab strip while the vertical tab strip is in a collapsed state, the vertical tab strip is expanded from the collapsed state to an expanded state. In response to termination of the user hover interaction, the vertical tab strip is collapsed from the expanded state to the collapsed state. The vertical tab strip in the collapsed state occupies a smaller portion of the GUI then the vertical tab strip in the expanded state.Type: GrantFiled: November 21, 2022Date of Patent: September 3, 2024Assignee: MICROSOFT TECHNOLOGY LICENSING, LLCInventors: William J. Devereux, Jerin R. Schneider, Olga Veselova, Patrick Evan Little, Warren C. Stevens, Darryl J. Brown, Michael H. Catbagan, Aaron M. Butcher, Daniel J. Krenn
-
Publication number: 20240218374Abstract: Described herein are aptamers capable of binding to coronavirus protein(s); compositions comprising a coronavirus protein binding aptamer with a coronavirus protein; and methods of making and using the same.Type: ApplicationFiled: April 14, 2022Publication date: July 4, 2024Applicant: Somalogic Operating Co., Inc.Inventors: Amy D. Gelinas, Daniel J. Schneider, Nebojsa Janjic
-
Publication number: 20230406368Abstract: A system for improved intermodal freight transportation is described herein. Improved carriages and support trusses are provided that beneficially move the load-bearing structure to interconnected support trusses forming a top-end spine of the train with freight containers equipped with wheels hanging underneath. Upon entering a terminal, the floor adjacent to the rails may be configured to gradually rise until the container's wheels are supporting the container's weight. When properly aligned with a container exchange station, the container's connections to the train may be configured to release the container from the train, and the container's wheels may be configured to pivot, allowing the container to be rolled to the side of the train and replaced by another. This may allow the container to be replaced without having to lift the container or disconnect any of the rolling stock components.Type: ApplicationFiled: August 2, 2023Publication date: December 21, 2023Inventor: Daniel J. SCHNEIDER
-
Patent number: 11753051Abstract: A system for improved intermodal freight transportation is described herein. Improved carriages and support trusses are provided that beneficially move the load-bearing structure to interconnected support trusses forming a top-end spine of the train with freight containers equipped with wheels hanging underneath. Upon entering a terminal, the floor adjacent to the rails may be configured to gradually rise until the container's wheels are supporting the container's weight. When properly aligned with a container exchange station, the container's connections to the train may be configured to release the container from the train, and the container's wheels may be configured to pivot, allowing the container to be rolled to the side of the train and replaced by another. This may allow the container to be replaced without having to lift the container or disconnect any of the rolling stock components.Type: GrantFiled: September 4, 2020Date of Patent: September 12, 2023Inventor: Daniel J. Schneider
-
Publication number: 20220090080Abstract: The present disclosure describes improved SELEX methods for producing aptamers that are capable of binding to target molecules and improved photoSELEX methods for producing photoreactive aptamers that are capable of both binding and covalently crosslinking to target molecules. Specifically, the present disclosure describes methods for producing aptamers and photoaptamers having slower dissociation rate constants than are obtained using prior SELEX and photoSELEX methods. The disclosure further describes aptamers and photoaptamers having slower dissociation rate constants than those obtained using prior methods. In addition, the disclosure describes aptamer constructs that include a variety of functionalities, including a cleavable element, a detection element, and a capture or immobilization element.Type: ApplicationFiled: August 11, 2021Publication date: March 24, 2022Applicant: SomaLogic, Inc.Inventors: Dominic ZICHI, Sheri K WILCOX, Chris BOCK, Daniel J. SCHNEIDER, Bruce EATON, Larry GOLD
-
Publication number: 20210317456Abstract: Described herein are aptamers capable of binding to immunoglobulin G (IgG); compositions comprising an IgG binding aptamer with an IgG protein; and methods of making and using the same. Provided herein are also methods of releasing proteins bound to aptamers.Type: ApplicationFiled: October 15, 2019Publication date: October 14, 2021Applicant: SomaLogic, Inc.Inventors: Steven K. Wolk, Jessica Guillot, Erik Zimmerman, Michael Vrklijan, Allison Weiss, Daniel W. Drolet, Daniel J. Schneider, Sheri Wilcox, Nebojsa Janjic
-
Patent number: 11111495Abstract: The present disclosure describes improved SELEX methods for producing aptamers that are capable of binding to target molecules and improved photoSELEX methods for producing photoreactive aptamers that are capable of both binding and covalently crosslinking to target molecules. Specifically, the present disclosure describes methods for producing aptamers and photoaptamers having slower dissociation rate constants than are obtained using prior SELEX and photoSELEX methods. The disclosure further describes aptamers and photoaptamers having slower dissociation rate constants than those obtained using prior methods. In addition, the disclosure describes aptamer constructs that include a variety of functionalities, including a cleavable element, a detection element, and a capture or immobilization element.Type: GrantFiled: May 16, 2019Date of Patent: September 7, 2021Assignee: Somalogic, Inc.Inventors: Dominic Zichi, Sheri K. Wilcox, Chris Bock, Daniel J. Schneider, Bruce Eaton, Larry Gold
-
Publication number: 20210070327Abstract: A system for improved intermodal freight transportation is described herein. Improved carriages and support trusses are provided that beneficially move the load-bearing structure to interconnected support trusses forming a top-end spine of the train with freight containers equipped with wheels hanging underneath. Upon entering a terminal, the floor adjacent to the rails may be configured to gradually rise until the container's wheels are supporting the container's weight. When properly aligned with a container exchange station, the container's connections to the train may be configured to release the container from the train, and the container's wheels may be configured to pivot, allowing the container to be rolled to the side of the train and replaced by another. This may allow the container to be replaced without having to lift the container or disconnect any of the rolling stock components.Type: ApplicationFiled: September 4, 2020Publication date: March 11, 2021Inventor: Daniel J. SCHNEIDER
-
Patent number: 10648972Abstract: The present disclosure describes methods, devices, reagents, and kits for the detection of one or more target molecules that may be present in a test sample. In one embodiment, a test sample is contacted with an aptamer that includes a tag and has a specific affinity for a target molecule. An aptamer affinity complex that includes an aptamer bound to its target molecule is allowed to form. If the test sample contains the target molecule, an aptamer affinity complex will generally form in the test sample. The aptamer affinity complex is optionally converted to an aptamer covalent complex that includes an aptamer covalently bound to its target molecule. The aptamer affinity complex (or optional aptamer covalent complex) can then be detected and/or quantified using any of a variety of methods known to one skilled in the art, including using a solid support, using mass spectrometry, and using quantitative polymerase chain reaction (Q-PCR).Type: GrantFiled: January 23, 2018Date of Patent: May 12, 2020Assignee: SomaLogic, Inc.Inventors: James R. Heil, Daniel J. Schneider, Daniel T. Nieuwlandt, Sheri K. Wilcox, Dominic Zichi, Todd Gander, Bruce Eaton, Larry Gold
-
Publication number: 20190330634Abstract: The present disclosure describes improved SELEX methods for producing aptamers that are capable of binding to target molecules and improved photoSELEX methods for producing photoreactive aptamers that are capable of both binding and covalently crosslinking to target molecules. Specifically, the present disclosure describes methods for producing aptamers and photoaptamers having slower dissociation rate constants than are obtained using prior SELEX and photoSELEX methods. The disclosure further describes aptamers and photoaptamers having slower dissociation rate constants than those obtained using prior methods. In addition, the disclosure describes aptamer constructs that include a variety of functionalities, including a cleavable element, a detection element, and a capture or immobilization element.Type: ApplicationFiled: May 16, 2019Publication date: October 31, 2019Inventors: Dominic Zichi, Sheri K. Wilcox, Chris Bock, Daniel J. Schneider, Bruce Eaton, Larry Gold
-
Patent number: 10422794Abstract: The present disclosure describes methods, devices, reagents, and kits for the detection of one or more target molecules that may be present in a test sample. In one embodiment, a test sample is contacted with an aptamer that includes a tag and has a specific affinity for a target molecule. An aptamer affinity complex that includes an aptamer bound to its target molecule is allowed to form. If the test sample contains the target molecule, an aptamer affinity complex will generally form in the test sample. The aptamer affinity complex is optionally converted to an aptamer covalent complex that includes an aptamer covalently bound to its target molecule. The aptamer affinity complex (or optional aptamer covalent complex) can then be detected and/or quantified using any of a variety of methods known to one skilled in the art.Type: GrantFiled: December 12, 2014Date of Patent: September 24, 2019Assignee: SomaLogic, Inc.Inventors: James R. Heil, Daniel J. Schneider, Daniel T. Nieuwlandt, Sheri K. Wilcox, Dominic Zichi, Todd Gander, Bruce Eaton, Larry Gold
-
Publication number: 20190264208Abstract: The present disclosure describes improved SELEX methods for producing aptamers that are capable of binding to target molecules and improved photoSELEX methods for producing photoreactive aptamers that are capable of both binding and covalently crosslinking to target molecules. Specifically, the present disclosure describes methods for producing aptamers and photoaptamers having slower dissociation rate constants than are obtained using prior SELEX and photoSELEX methods. The disclosure further describes aptamers and photoaptamers having slower dissociation rate constants than those obtained using prior methods. In addition, the disclosure describes aptamer constructs that include a variety of functionalities, including a cleavable element, a detection element, and a capture or immobilization element.Type: ApplicationFiled: May 16, 2019Publication date: August 29, 2019Inventors: Dominic Zichi, Sheri K. Wilcox, Chris Bock, Daniel J. Schneider, Bruce Eaton, Larry Gold
-
Patent number: 10316321Abstract: The present disclosure describes improved SELEX methods for producing aptamers that are capable of binding to target molecules and improved photoSELEX methods for producing photoreactive aptamers that are capable of both binding and covalently crosslinking to target molecules. Specifically, the present disclosure describes methods for producing aptamers and photoaptamers having slower dissociation rate constants than are obtained using prior SELEX and photoSELEX methods. The disclosure further describes aptamers and photoaptamers having slower dissociation rate constants than those obtained using prior methods. In addition, the disclosure describes aptamer constructs that include a variety of functionalities, including a cleavable element, a detection element, and a capture or immobilization element.Type: GrantFiled: January 23, 2018Date of Patent: June 11, 2019Assignee: SomaLogic Inc.Inventors: Dominic Zichi, Sheri K. Wilcox, Chris Bock, Daniel J. Schneider, Bruce Eaton, Larry Gold
-
Publication number: 20180155725Abstract: The present disclosure describes improved SELEX methods for producing aptamers that are capable of binding to target molecules and improved photoSELEX methods for producing photoreactive aptamers that are capable of both binding and covalently crosslinking to target molecules. Specifically, the present disclosure describes methods for producing aptamers and photoaptamers having slower dissociation rate constants than are obtained using prior SELEX and photoSELEX methods. The disclosure further describes aptamers and photoaptamers having slower dissociation rate constants than those obtained using prior methods. In addition, the disclosure describes aptamer constructs that include a variety of functionalities, including a cleavable element, a detection element, and a capture or immobilization element.Type: ApplicationFiled: January 23, 2018Publication date: June 7, 2018Applicant: SomaLogic, Inc.Inventors: Dominic Zichi, Sheri K. Wilcox, Chris Bock, Daniel J. Schneider, Bruce Eaton, Larry Gold
-
Publication number: 20180156787Abstract: The present disclosure describes methods, devices, reagents, and kits for the detection of one or more target molecules that may be present in a test sample. In one embodiment, a test sample is contacted with an aptamer that includes a tag and has a specific affinity for a target molecule. An aptamer affinity complex that includes an aptamer bound to its target molecule is allowed to form. If the test sample contains the target molecule, an aptamer affinity complex will generally form in the test sample. The aptamer affinity complex is optionally converted to an aptamer covalent complex that includes an aptamer covalently bound to its target molecule. The aptamer affinity complex (or optional aptamer covalent complex) can then be detected and/or quantified using any of a variety of methods known to one skilled in the art, including using a solid support, using mass spectrometry, and using quantitative polymerase chain reaction (Q-PCR).Type: ApplicationFiled: January 23, 2018Publication date: June 7, 2018Inventors: James R. Heil, Daniel J. Schneider, Daniel T. Nieuwlandt, Sheri K. Wilcox, Dominic Zichi, Todd Gander, Bruce Eaton, Larry Gold
-
Publication number: 20170137819Abstract: The present disclosure describes improved SELEX methods for producing aptamers that are capable of binding to target molecules and improved photoSELEX methods for producing photoreactive aptamers that are capable of both binding and covalently crosslinking to target molecules. Specifically, the present disclosure describes methods for producing aptamers and photoaptamers having slower dissociation rate constants than are obtained using prior SELEX and photoSELEX methods. The disclosure further describes aptamers and photoaptamers having slower dissociation rate constants than those obtained using prior methods. In addition, the disclosure describes aptamer constructs that include a variety of functionalities, including a cleavable element, a detection element, and a capture or immobilization element.Type: ApplicationFiled: January 19, 2017Publication date: May 18, 2017Inventors: Dominic Zichi, Sheri K. Wilcox, Chris Bock, Daniel J. Schneider, Bruce Eaton, Larry Gold
-
Patent number: 9404919Abstract: The present disclosure describes methods, devices, reagents, and kits for the detection of one or more target molecules that may be present in a test sample. The described methods, devices, kits, and reagents facilitate the detection and quantification of a non-nucleic acid target (e.g., a protein target) in a test sample by detecting and quantifying a nucleic acid (i.e., an aptamer). The methods described create a nucleic acid surrogate for a non-nucleic acid target, thus allowing the wide variety of nucleic acid technologies, including amplification, to be applied to a broader range of desired targets, especially protein targets. The disclosure further describes aptamer constructs that facilitate the use of aptamers in a variety of analytical detection applications.Type: GrantFiled: February 10, 2014Date of Patent: August 2, 2016Assignee: SOMALOGIC, INC.Inventors: Daniel J. Schneider, Dan Nieuwlandt, Bruce Eaton, Martin Stanton, Shashi Gupta, Stephan Kraemer, Dominic Zichi, Larry Gold
-
Patent number: 9382533Abstract: The present disclosure describes the identification and use of aptamers and photoaptamers having slower dissociation rate constants than those obtained using previously described methods. Specifically, the present disclosure describes methods for the identification and use of aptamers to one or more targets within a histological or cytological sample, which have slow rates of dissociation. The aptamers may be used to assess localization, relative density, and presence or absence of one or more targets in cytological and histological samples. Targets may be selected that are specific and diagnostic of a given disease state for which the sample was collected. The aptamers may also be used to introduce target specific signal moieties. In addition to target identification, the aptamers may be used to amplify signal generation through a variety of methods.Type: GrantFiled: January 27, 2015Date of Patent: July 5, 2016Assignee: SomaLogic, Inc.Inventors: Dominic Zichi, Sheri K. Wilcox, Chris Bock, Daniel J. Schneider, Bruce Eaton, Larry Gold, Thale C. Jarvis, Jeffrey D. Carter
-
Patent number: 9365855Abstract: The present disclosure relates generally to the field of nucleic acids and, more particularly, to aptamers capable of binding to 4-1BB; pharmaceutical compositions comprising such 4-1BB aptamers; and methods of making and using the same.Type: GrantFiled: November 19, 2013Date of Patent: June 14, 2016Assignee: SOMALOGIC, INC.Inventors: Jonathan Vaught, Daniel I. Resnicow, Sheela Waugh, Sheri K. Wilcox, Daniel J. Schneider
-
Patent number: 9206429Abstract: Aptamers that bind IL-6 are provided. Pharmaceutical compositions comprising IL-6 aptamers are provided, as well as methods of treating conditions using the aptamers are also provided.Type: GrantFiled: March 12, 2014Date of Patent: December 8, 2015Assignees: SomaLogic, Inc., Otsuka Pharmaceutical Co., LtdInventors: Shashi Gupta, Masao Hirota, Daniel J. Schneider, Tomoki Suzuki, Thale C. Jarvis, Yuichi Ishikawa, Ikuo Murakami, Amy Gelinas, Sheela Waugh, Nebojsa Janjic